Article Information
History
- October 10, 2019.
Article Versions
- You are currently viewing Version 1 of this article (October 10, 2019 - 16:20).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Andres F. Vallejo1,
- James Davies1,
- Amit Grover2,
- Ching-Hsuan Tsai3,
- Robert Jepras2,
- Marta E. Polak*,1,4,6 and
- Jonathan West*,4,5,6
- 1Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, SO16 6YD, Southampton, UK
- 2GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK
- 3GlaxoSmithKline, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, MA 02140, USA
- 4Institute for Life Sciences, University of Southampton, SO17 1BJ, UK
- 5Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
- ↵*Correspondence to: Dr Jonathan West e-mail: J.J.West{at}soton.ac.uk, Dr Marta E Polak e-mail: m.e.polak{at}soton.ac.uk
Authors contributions: AFV, MEP and JW conceived the idea, planned the experiments and wrote the manuscript. AFV, JD and AG performed the experiments. AFV and MEP analysed the data. AG, CHT and RJ contributed to the experimental plan and reviewed the manuscript.